IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

RP Management, LLC

Q3 2019 Holdings

Filed 2019-11-14 | 4 holdings | $10.1M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Cytokinetics Inc(CYTK)COM NEW23282W605$10.0M875,65698.6%
Biohaven Pharmactl Hldg Co L(BHVN)COMG11196105$88.1K2,111,1110.9%
Immunomedics Inc(IMMU)COM452907108$58.0K4,373,1780.6%
Sunesis Pharmaceuticals IncCOM867328700$93129,5170.0%